<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00801710</url>
  </required_header>
  <id_info>
    <org_study_id>200-0001</org_study_id>
    <nct_id>NCT00801710</nct_id>
  </id_info>
  <brief_title>CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study</brief_title>
  <official_title>CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BridgePoint Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BridgePoint Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to determine if the BridgePoint Medical System (CrossBoss Catheter, Stingray
      Catheter, Entera Guidewire) can facilitate safe and effective placement of a guidewire in the
      true lumen of coronary vessels distal to a chronic total occlusion (CTO).

      The hypothesis is that the BridgePoint Medical System can do this without an increase in
      major complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CTO Crossing Rate</measure>
    <time_frame>Peri-procedural</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events (MACE)</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perforation rate</measure>
    <time_frame>Peri-procedural</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute myocardial infarction (AMI)</measure>
    <time_frame>Peri-procedural</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Artery Chronic Total Occlusion</condition>
  <arm_group>
    <arm_group_label>BridgePoint Medial System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BridgePoint Medical System (CrossBoss Catheter, Stingray Catheter, Entera Guidewire)</intervention_name>
    <description>Revascularization of coronary artery chronic total occlusion.
Use of the BridgePoint Medical System to cross coronary CTOs prior to definitive revascularization treatment via angioplasty and/or stent implant</description>
    <arm_group_label>BridgePoint Medial System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suitable for coronary intervention

          -  de novo or restenotic CTO at least 3 months old, in proximal or mid coronary artery
             segment, 3.0-5.0 mm in diameter

          -  Mild/moderate proximal vessel tortuosity

          -  Mild/moderate lesion angulation

          -  Mild/moderate calcification

          -  Satisfactory distal vessel visualization

          -  Mild/moderate side branch interference

          -  19 years old

          -  BMI&lt;40

          -  LVEF&gt;20%

          -  Signed informed consent

        Exclusion Criteria:

          -  Extensive dissection from guidewire manipulation

          -  SVG or in-stent CTO

          -  Aorto-ostial CTO

          -  Unable to take aspirin, Clopidogrel, or Ticlopidine

          -  Thrombus/vessel filling defects

          -  Severe cerebrovascular disease/stroke within 1 month

          -  Intervention within 2 weeks

          -  Renal insufficiency

          -  GI bleeding

          -  Active infection

          -  Life expectancy &lt;2 years

          -  Significant anemia

          -  Uncontrolled hypertension

          -  Severe electrolyte imbalance

          -  Anaphylaxis to contrast

          -  NYHA class IV

          -  Unstable angina requiring intervention

          -  MI within 2 weeks

          -  Uncontrolled diabetes

          -  Participating in another protocol

          -  Unwilling/unable to comply with protocol

          -  Angina/ischemia caused by target vessel
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Sievert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CardioVascular Center Frankfurt, St. Katharinen Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Main Taunus Hospital</name>
      <address>
        <city>Bad Soden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Darmstadt</name>
      <address>
        <city>Darmstadt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVascular Center Frankfurt, St. Katharinen Hospital</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäres Herz- und Gefässzentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2008</study_first_submitted>
  <study_first_submitted_qc>December 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2008</study_first_posted>
  <last_update_submitted>December 2, 2009</last_update_submitted>
  <last_update_submitted_qc>December 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>John Schultz, Vice President, Clinical Affairs</name_title>
    <organization>BridgePoint Medical</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

